Trial Profile
LY2452473 Formulation Exploratory Bioavailability Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2019
Price :
$35
*
At a glance
- Drugs LY 2452473/tadalafil (Primary) ; OPK 88004; Tadalafil
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- 12 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Jul 2011 New trial record